No problem. The sales figures in the half year and full year FY24 reports will obviously be the best source of new investors but it is definitely fantastic to see them engaging in events like this to hopefully get a bit more interest in advance of those reports. This has definitely always been a very tightly held stock. The CR investors changed that for a bit but they seem to have been all washed out and replaced by long termers.
Still can't fathom how the share price is so low though. This is a company generating revenue with a very strong and loyal customer base. Recurring revenue, very high gross margins, countless patents, solid and experienced management team, a brand new best in class product, enormous R&D pipeline, high growth and large markets... the list goes on - everything screams a high quality company deserving of a premium valuation
- Forums
- ASX - By Stock
- Nova Eye Medical (EYE) Discussion
No problem. The sales figures in the half year and full year...
-
-
- There are more pages in this discussion • 2,260 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EYE (ASX) to my watchlist
|
|||||
Last
24.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $54.91M |
Open | High | Low | Value | Volume |
24.0¢ | 24.5¢ | 24.0¢ | $110.1K | 458.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 432506 | 23.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
24.0¢ | 169560 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 432506 | 0.235 |
2 | 93400 | 0.230 |
3 | 75000 | 0.225 |
6 | 187721 | 0.220 |
3 | 188594 | 0.215 |
Price($) | Vol. | No. |
---|---|---|
0.240 | 169560 | 3 |
0.250 | 3996 | 1 |
0.255 | 16768 | 2 |
0.260 | 50000 | 1 |
0.265 | 70000 | 3 |
Last trade - 16.10pm 25/07/2024 (20 minute delay) ? |
Featured News
EYE (ASX) Chart |